S. Shaikh

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

J. Sampalis, P. Rahman, M. Khraishi, 2016, BMJ Open.

Early undifferentiated arthritis.

C. Hitchon, H. El-Gabalawy, C. Peschken, 2005, Rheumatic diseases clinics of North America.

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment

C. Zerbini, P. Durez, T. Takeuchi, 2017, Arthritis Research & Therapy.

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

B. Haraoui, M. Khraishi, J. Syrotuik, 2019, Therapeutic advances in musculoskeletal disease.

Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study

J. Sampalis, E. Keystone, S. Jamal, 2022, Arthritis care & research.

SAT0126 Evaluation of two dosing regimens of certolizumab pegol for maintenance of clinical response in patients with active rheumatoid arthritis: Primary results from doseflex, a phase IIIB study

D. Furst, M. Greenwald, W. Koetse, 2013 .

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

B. Devellis, B. Gandek, R. Devellis, 2015, Arthritis care & research.